ClinicalTrials.gov
ClinicalTrials.gov Menu

Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00028366
Recruitment Status : Completed
First Posted : December 28, 2001
Last Update Posted : August 16, 2012
Sponsor:
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)